Javascript must be enabled to continue!
Brca1 Is Regulated by the Transcription Factor Gata3, and Its Silencing Promotes Neural Differentiation in Retinal Neurons
View through CrossRef
Previous studies have indicated that Brca1 (Breast cancer suppressor gene 1) plays an important role in neural development and degenerative diseases. However, the bioactivity and regulatory mechanism of Brca1 expression in retinal neurocytes remain unclear. In the present study, our data indicated that Brca1 maintains the state of neuronal precursor cells. Brca1 silencing induces differentiation in 661W cells. Nestin, a marker of precursor cells, was significantly decreased in parallel with Brca1 silencing in 661W cells, whereas Map2 (Microtubule associated protein 2), a marker of differentiated neurons, was significantly increased. Neurite outgrowth was increased by ~4.0-fold in Brca1-silenced cells. Moreover, DNA affinity purification assays and ChIP assays demonstrated that Gata3 (GATA binding protein 3) regulates Brca1 transcription in 661W cells. Silencing or overexpressing Gata3 could significantly regulate the expression of Brca1 and affect its promoter inducibility. Furthermore, the expression of Gata3 generally occurred in parallel with that of Brca1 in developing mouse retinas. Both Gata3 and Brca1 are expressed in the neonatal mouse retina but are developmentally silenced with age. Exogenous Gata3 significantly inhibited neural activity by decreasing synaptophysin and neurite outgrowth. Thus, this study demonstrated that Brca1 is transcriptionally regulated by Gata3. Brca1/Gata3 silencing is involved in neuronal differentiation and maturation.
Title: Brca1 Is Regulated by the Transcription Factor Gata3, and Its Silencing Promotes Neural Differentiation in Retinal Neurons
Description:
Previous studies have indicated that Brca1 (Breast cancer suppressor gene 1) plays an important role in neural development and degenerative diseases.
However, the bioactivity and regulatory mechanism of Brca1 expression in retinal neurocytes remain unclear.
In the present study, our data indicated that Brca1 maintains the state of neuronal precursor cells.
Brca1 silencing induces differentiation in 661W cells.
Nestin, a marker of precursor cells, was significantly decreased in parallel with Brca1 silencing in 661W cells, whereas Map2 (Microtubule associated protein 2), a marker of differentiated neurons, was significantly increased.
Neurite outgrowth was increased by ~4.
0-fold in Brca1-silenced cells.
Moreover, DNA affinity purification assays and ChIP assays demonstrated that Gata3 (GATA binding protein 3) regulates Brca1 transcription in 661W cells.
Silencing or overexpressing Gata3 could significantly regulate the expression of Brca1 and affect its promoter inducibility.
Furthermore, the expression of Gata3 generally occurred in parallel with that of Brca1 in developing mouse retinas.
Both Gata3 and Brca1 are expressed in the neonatal mouse retina but are developmentally silenced with age.
Exogenous Gata3 significantly inhibited neural activity by decreasing synaptophysin and neurite outgrowth.
Thus, this study demonstrated that Brca1 is transcriptionally regulated by Gata3.
Brca1/Gata3 silencing is involved in neuronal differentiation and maturation.
Related Results
Abstract 1563: Damage-induced BRCA1 phosphorylation contributes to the timing of end resection
Abstract 1563: Damage-induced BRCA1 phosphorylation contributes to the timing of end resection
Abstract
Germline mutations of BRCA1 predispose women to breast and ovarian cancers. BRCA1 functions as a tumor suppressor. A wealth of evidence has established that...
Abstract 1505: GATA3 expression is associated with poor differentiation of osteosarcoma cells
Abstract 1505: GATA3 expression is associated with poor differentiation of osteosarcoma cells
Abstract
Objective: GATA3, a transcriptional factor promoting differentiation of Th2 cells, was expressed in breast cancer cells or bladder cancer cells. We reported...
Abstract 1716: Evaluating the functional impacts of the BRCA1-mTORC2 interaction in breast cancer
Abstract 1716: Evaluating the functional impacts of the BRCA1-mTORC2 interaction in breast cancer
Abstract
Objective: The BRCA1 C-Terminal (BRCT) domain of BRCA1 has been found to interact with three accessory proteins (PRR5, RICTOR, and SIN1) of mTOR complex ...
Abstract 1453: Transcriptoma analyses in triple-negative breast cancer with BRCA1 germline mutation
Abstract 1453: Transcriptoma analyses in triple-negative breast cancer with BRCA1 germline mutation
Abstract
Triple-negative breast cancer (TNBC), characterized by lack of expression of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal grow...
Retinal Oximetry
Retinal Oximetry
Abstract.Purpose:Malfunction of retinal blood flow or oxygenation is believed to be involved in various diseases. Among them are retinal vessel occlusions, diabetic retinopathy and...
Identification of shared neoantigens in BRCA1-related breast cancer
Identification of shared neoantigens in BRCA1-related breast cancer
Personalized neoantigen-based cancer vaccine has been shown to be safe and immunogenic in cancer patients; however, the manufacturing process can be costly and brings about delay i...
Pregnancy Hormone Mediated Tumorigenesis in BRCA1 Defective Breast Cancers
Pregnancy Hormone Mediated Tumorigenesis in BRCA1 Defective Breast Cancers
Background and Objective
BRCA1 mutations predispose to breast and ovarian cancers, the exact reason for the tissue specificity is unknown. The role of hormonal ...
Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes
Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes
Aims
GATA-binding protein 3 (GATA3) is a sensitive and relatively specific marker in breast and urothelial carcinomas. Its diagnostic utility in primary and met...

